Skip to content
The Policy VaultThe Policy Vault

Nexavar (sorafenib) — Medica

Gastrointestinal stromal tumor (GIST)

Initial criteria

  • age ≥ 18 years
  • previous trials of imatinib or Ayvakit, Sutent or Sprycel, Stivarga, and Qinlock

Approval duration

1 year